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Chorea and convulsive seizures are rare consequences of
hyperthyroidism [1, 2]. We describe the case of such
manifestation of autoimmune thyroid disease.
In 2003, a 23-year-old woman presented with the first
symptoms of hyperthyroidism—palpitations, weight loss
and exercise intolerance. TSH and fT4 concentrations were
0.01 lIU/ml and 43 pmol/l, respectively (norm: TSH
0.35–4.9 lIU/ml, fT4 11.5–23.2 pmol/l). The patient was
treated with thiamazole in tapering doses (from 60 to 10 mg
per day). After 2 months, hypothyreosis was observed and
thiamazole was withdrawn. 2 weeks later, the signs of thy-
rotoxicosis and involuntary movements of the left extremi-
ties appeared. Hyperthyreosis was verified (fT4 87.3 pmol/l)
and treatment with propylothiouracil (600 mg per day) was
initiated. Neurological examination confirmed left-sided
hemichorea. Elevated levels of TSH receptor antibodies
(TRAb) and thyroperoxidase autoantibodies (TPO Ab) were
documented: 16.7 and 257.5 IU/ml, respectively (norm:
0.1–1.22 IU/ml and \60 IU/ml, respectively). Biopsy
specimen of the thyroid showed lymphocytic infiltration,
typical of lymphocytic thyroiditis. The patient had no family
history of neurological disorders or dementia syndromes.
Ceruloplasmin and copper concentrations were normal,
similar to anticardiolipin, antistreptolysin O, and anti-neu-
trophil cytoplasm antibodies. Antinuclear and anti-double-
stranded DNA antibodies were negative. Cerebrospinal fluid
examination and MRI of the brain were normal, and borre-
liosis and toxoplasmosis were ruled out based on immuno-
logical examination of serum and cerebrospinal fluid. EEG
revealed slight changes in the posterior temporal and
occipital leads: theta waves and isolated sharp waves, pre-
dominantly in the right hemisphere, along with slight
changes of paroxysmal character in the frontal and anterior
temporal leads. Haloperidol (6 mg per day) and thioridazin
(50 mg per day) were administered. fT4 concentrations
diminished (28.7 pmol/l) and choreic movements consid-
erably subsided.
Treatment with a maintenance dose of thiamazole was
continued. Prednisone (60 mg per day, with 5 mg reduc-
tion every week) was administered. The dosages of neu-
roleptics were reduced and finally withdrawn. Choreic
movements diminished gradually to disappear completely
within 6 weeks. The return of chorea has not been observed
so far.
For over a year, during treatment with thiamazole
(2.5 mg per day), the patient was euthyroid. In October
2005, in the first trimester of pregnancy, symptoms of
thyreotoxicosis were once again reported. TSH and fT4
concentrations were 0.02 lIU/ml and 51.73 pmol/l,
respectively. Thiamazole was withdrawn and propylothio-
uracil (initially 150 mg per day) was administered. It was
withdrawn in the third trimester, when serum fT4 decreased
to 14.7 pmol/l. 3 months after the delivery, signs of hy-
perthyreosis were observed (fT4 = 41.7 pmol/l), and treat-
ment with propylothiouracil (150 mg/day) was reinstated.
In October 2006, the patient presented with generalized
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tonic–clonic convulsive seizures, loss of consciousness and
retrograde amnesia. fT3 and fT4 concentrations were ele-
vated (20.11 pg/ml and 5.19 ng/dl, respectively; norm:
1.71–3.71 pg/ml and 0.71–1.85 ng/dl, respectively). Labo-
ratory tests and MRI of the brain were normal. Antithyroid
treatment was intensified and the patient became euthyroid
in December 2006. TPO Ab and anti-thyroglobulin anti-
bodies (Tg Ab) were elevated (872.7 and 194.8 IU/ml,
respectively; norm \60 IU/ml). In June 2008, the patient
underwent treatment with radioactive iodine 131I
(150 MBq).
Between January 2009 and August 2010, the patient was
euthyroid and did not receive any pharmacotherapy. Dur-
ing this period of time, she started to suffer from depres-
sion, difficulties with her memory, and sleep disturbances.
Psychological examination confirmed mild cognitive
impairment and mood disorder. Single-photon emission
computed tomography of the brain showed slight global
hypoperfusion in both cerebral hemispheres, and an uni-
lateral reduction in the regional blood flow of the left
parietal lobe, left temporal lobe and left insula. MRI of the
brain was normal. EEG revealed slight changes in frontal
and temporal leads in the form of theta waves and isolated
sharp waves, accompanied by minor paroxysmal features
observed in the posterior temporal and occipital leads.
In January 2010, levels of TPO Ab were still elevated
(324 IU/ml), while TG Ab and TRAb were normal. In
August 2010, subclinical hypothyreosis was diagnosed
(TSH 6.13 lIU/ml, fT4 1.36 ng/dl) and treatment with L-
thyroxin (25 lg/day) was initiated. Cognitive function
deterioration has not been observed thus far.
The pathophysiological mechanism underlying hyper-
thyroidism-induced chorea is unclear. In most reported
cases, choreoathetosis was observed during thyreotoxic
states, and one cannot exclude autoimmune mechanisms
underlying the chorea [2, 3]. Morphological changes in the
basal ganglia are another potential cause of chorea in
patients with hyperthyroidism [3]. Seizures are one of the
clinical features of encephalopathy associated with auto-
immune thyroiditis, often termed Hashimoto’s encepha-
lopathy. The exact pathomechanism of this disease is still
not fully understood. Its neurological symptoms can result
from autoimmune inflammation of minute cerebral vessels,
with the involvement of anti-TPO antibodies [4].
Hereby, presented case illustrates that cognitive
impairment may be an unusual consequence of autoim-
mune thyroid disease, and thyroid function should be
examined in subjects with encephalopathy, chorea and
seizures.
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